Condition

Cervical Neoplasia

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 3 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials3

Recruiting0

Common interventions3

Lead sponsors shown2

Clinical trials

3 shown

Feasibility Study Comparing One vs Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive WLWH in C1001P-CS9 South AfricaNCT07645378 · 2026-10-15

NOT_YET_RECRUITING

Feasibility Study Comparing One vs Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive Women Living With HIV in C1001P-CS7 ZimbabweNCT07645352 · 2026-10-15

NOT_YET_RECRUITING

Cervical Cancer Screening in HIV Positive and Negative Women in CambodiaNCT02253719 · 2014-10-01

COMPLETED

Common interventions

Thermal ablation (TA) with 1 probePROCEDURE2 Thermal ablation (TA) with 2 probesPROCEDURE2 cryotherapy, further biopsy, LEEP, surgery as indicatedPROCEDURE1

Leading sponsors

Fred Hutchinson Cancer Center 2 Sihanouk Hospital Center of HOPE 1

Trial status mix

NOT_YET_RECRUITING2

COMPLETED1

Phase mix

NA2

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.